Brief: Neuren Pharmaceuticals Posts Qtrly Net Sales Of Us$84.6 Mln
07/08/2024 02:06
Aug 7 (Reuters) - Neuren Pharmaceuticals Ltd NEU.AX :
* NET SALES OF US$84.6 MILLION FOR Q2 2024 BY PARTNER ACADIA
PHARMACEUTICALS
* UPDATED GUIDANCE FOR NET SALES IN 2024 OF US$340-370
MILLION FOR
ACADIA PHARMACEUTICALS
Further company coverage: NEU.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neuren Pharmaceuticals
See all newsAustralia's Neuren set for weekly gain on FDA nod, drug forecast upgrade
Australia's Neuren Pharmaceuticals gains on upbeat FY trofinetide earnings outlook
Australia's Neuren Pharma rises as US FDA grants orphan tag for NNZ-2591
Strong partner sales propel Neuren Pharmaceuticals to top of Australia benchmark
Brief: Neuren Pharmaceuticals Says DAYBU Recommended For Approval In European Union